PROM1 and glioblastoma: first described the concept of brain tumour initiating cells based on experimental data suggesting that only the Prominin 1/CD133+ population within GBM had the ability to initiate brain tumours in non-obese, diabetic/severe combined immunodeficiency (NOD/SCID) mice, compared with the CD133- negative population (13).